151 related articles for article (PubMed ID: 29075790)
1. Differential contribution of tissue factor and Factor XII to thrombin generation triggered by breast and pancreatic cancer cells.
Rousseau A; Larsen AK; Van Dreden P; Sabbah M; Elalamy I; Gerotziafas GT
Int J Oncol; 2017 Dec; 51(6):1747-1756. PubMed ID: 29075790
[TBL] [Abstract][Full Text] [Related]
2. Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7.
Gerotziafas GT; Galea V; Mbemba E; Khaterchi A; Sassi M; Baccouche H; Prengel C; van Dreden P; Hatmi M; Bernaudin JF; Elalamy I
Thromb Res; 2012 Jun; 129(6):779-86. PubMed ID: 21917301
[TBL] [Abstract][Full Text] [Related]
3. Procoagulant microparticles derived from cancer cells have determinant role in the hypercoagulable state associated with cancer.
Rousseau A; Van Dreden P; Khaterchi A; Larsen AK; Elalamy I; Gerotziafas GT
Int J Oncol; 2017 Dec; 51(6):1793-1800. PubMed ID: 29075792
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles derived from pancreatic cancer cells BXPC3 or breast cancer cells MCF7 induce a permanent procoagulant shift to endothelial cells.
AmraneDjedidi R; Rousseau A; Larsen AK; Elalamy I; Van Dreden P; Gerotziafas GT
Thromb Res; 2020 Mar; 187():170-179. PubMed ID: 32006891
[TBL] [Abstract][Full Text] [Related]
5. Contact activation: important to consider when measuring the contribution of tissue factor-bearing microparticles to thrombin generation using phospholipid-containing reagents.
Boknäs N; Faxälv L; Lindahl TL; Ramström S
J Thromb Haemost; 2014 Apr; 12(4):515-8. PubMed ID: 24405583
[TBL] [Abstract][Full Text] [Related]
6. OC-03 - Modelisation of the procoagulant properties of cancer cells and their capacity to alter the antithrombotic efficiency of LMWHs and specific inhibitors of factor Xa.
Gerotziafas GT; Rousseau A; van Dreden P; Mbemba E; Gkalea V; Khaterchi A; Larsen A; Elalamy I
Thromb Res; 2016 Apr; 140 Suppl 1():S169. PubMed ID: 27161675
[TBL] [Abstract][Full Text] [Related]
7. The effect of corn trypsin inhibitor, anti-tissue factor pathway inhibitor antibodies and phospholipids on microvesicle-associated thrombin generation in patients with pancreatic cancer and healthy controls.
Hellum M; Franco-Lie I; Øvstebø R; Hauge T; Henriksson CE
PLoS One; 2017; 12(9):e0184579. PubMed ID: 28910348
[TBL] [Abstract][Full Text] [Related]
8. Factor VIIa-mediated tenase function on activated platelets under flow.
Goel MS; Diamond SL
J Thromb Haemost; 2004 Aug; 2(8):1402-10. PubMed ID: 15304047
[TBL] [Abstract][Full Text] [Related]
9. Cancer cells BXPC3 and MCF7 differentially reverse the inhibition of thrombin generation by apixaban, fondaparinux and enoxaparin.
Rousseau A; Van Dreden P; Mbemba E; Elalamy I; Larsen A; Gerotziafas GT
Thromb Res; 2015 Dec; 136(6):1273-9. PubMed ID: 26489727
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor and cancer procoagulant expressed by glioma cells participate in their thrombin-mediated proliferation.
Ogiichi T; Hirashima Y; Nakamura S; Endo S; Kurimoto M; Takaku A
J Neurooncol; 2000; 46(1):1-9. PubMed ID: 10896200
[TBL] [Abstract][Full Text] [Related]
11. Factor XII activation is essential to sustain the procoagulant effects of particulate matter.
Kilinç E; Van Oerle R; Borissoff JI; Oschatz C; Gerlofs-Nijland ME; Janssen NA; Cassee FR; Sandström T; Renné T; Ten Cate H; Spronk HM
J Thromb Haemost; 2011 Jul; 9(7):1359-67. PubMed ID: 21481175
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic insight into the procoagulant activity of tumor-derived apoptotic vesicles.
Muhsin-Sharafaldine MR; Kennedy BR; Saunderson SC; Buchanan CR; Dunn AC; Faed JM; McLellan AD
Biochim Biophys Acta Gen Subj; 2017 Feb; 1861(2):286-295. PubMed ID: 27864149
[TBL] [Abstract][Full Text] [Related]
13. The Antithrombotic Potential of Tinzaparin and Enoxaparin Upon Thrombin Generation Triggered In Vitro by Human Ovarian Cancer Cells IGROV1.
Sassi M; Chakroun T; Mbemba E; Van Dreden P; Elalamy I; Larsen AK; Gerotziafas GT
Clin Appl Thromb Hemost; 2017 Mar; 23(2):155-163. PubMed ID: 27609342
[TBL] [Abstract][Full Text] [Related]
14. Monitoring thrombin generation: is addition of corn trypsin inhibitor needed?
Spronk HM; Dielis AW; Panova-Noeva M; van Oerle R; Govers-Riemslag JW; Hamulyák K; Falanga A; Cate HT
Thromb Haemost; 2009 Jun; 101(6):1156-62. PubMed ID: 19492161
[TBL] [Abstract][Full Text] [Related]
15. All trans-retinoic acid modulates the procoagulant activity of human breast cancer cells.
Marchetti M; Russo L; Balducci D; Falanga A
Thromb Res; 2011 Oct; 128(4):368-74. PubMed ID: 21458031
[TBL] [Abstract][Full Text] [Related]
16. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
[TBL] [Abstract][Full Text] [Related]
17. Pancreatic cancer cell and microparticle procoagulant surface characterization: involvement of membrane-expressed tissue factor, phosphatidylserine and phosphatidylethanolamine.
Yates KR; Welsh J; Echrish HH; Greenman J; Maraveyas A; Madden LA
Blood Coagul Fibrinolysis; 2011 Dec; 22(8):680-7. PubMed ID: 21941170
[TBL] [Abstract][Full Text] [Related]
18. Simultaneous tissue factor expression and phosphatidylserine exposure account for the highly procoagulant pattern of melanoma cell lines.
Kirszberg C; Lima LG; Da Silva de Oliveira A; Pickering W; Gray E; Barrowcliffe TW; Rumjanek VM; Monteiro RQ
Melanoma Res; 2009 Oct; 19(5):301-8. PubMed ID: 19550359
[TBL] [Abstract][Full Text] [Related]
19. Modelization of Blood-Borne Hypercoagulability in Myeloma: A Tissue-Factor-Bearing Microparticle-Driven Process.
Papageorgiou L; Alhaj Hussen K; Thouroude S; Mbemba E; Cost H; Garderet L; Elalamy I; Larsen A; Van Dreden P; Dimopoulos MA; Mohty M; Gerotziafas GT
TH Open; 2019 Oct; 3(4):e340-e347. PubMed ID: 31693008
[No Abstract] [Full Text] [Related]
20. Expression of tissue factor in pancreatic adenocarcinoma is associated with activation of coagulation.
Haas SL; Jesnowski R; Steiner M; Hummel F; Ringel J; Burstein C; Nizze H; Liebe S; Löhr JM
World J Gastroenterol; 2006 Aug; 12(30):4843-9. PubMed ID: 16937466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
